Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROOHI NAJEEMUDDIN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Reproductive Endocrinology

NPI
1619302411
CMS profile
636960
Location
CHICAGO, IL

General Payments · PY2018–2024

$87,631.37

  • Reported across 193 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$27,322.93

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Ferring Pharmaceuticals Inc. $27,196.23 25
Organon LLC $80.89 5
Sumitomo Pharma America, Inc. $27.93 1
EMD Serono, Inc. $17.88 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $545.52 23
PY2019 $840.90 41
PY2020 $2,392.47 12
PY2021 $1,045.00 24
PY2022 $7,270.57 16
PY2023 $48,213.98 45
PY2024 $27,322.93 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
EMD Serono, Inc. $17.88 02/06/2024 Food and Beverage Undisputed 01/23/2026 1120223293 CMS
Ferring Pharmaceuticals Inc. $76.88 01/08/2024 Travel and Lodging Undisputed 01/23/2026 1137498117 CMS
Ferring Pharmaceuticals Inc. $444.80 01/08/2024 Travel and Lodging Undisputed 01/23/2026 1137498122 CMS
Ferring Pharmaceuticals Inc. $487.80 01/08/2024 Travel and Lodging Undisputed 01/23/2026 1137498126 CMS
Ferring Pharmaceuticals Inc. $189.60 01/08/2024 Travel and Lodging Undisputed 01/23/2026 1137498130 CMS
Ferring Pharmaceuticals Inc. $774.03 01/08/2024 Travel and Lodging Undisputed 01/23/2026 1137498134 CMS
Ferring Pharmaceuticals Inc. $65.80 01/09/2024 Travel and Lodging Undisputed 01/23/2026 1137498138 CMS
Ferring Pharmaceuticals Inc. $345.00 01/09/2024 Travel and Lodging Undisputed 01/23/2026 1137498143 CMS
Ferring Pharmaceuticals Inc. $2,334.00 01/11/2024 Consulting Fee Undisputed 01/23/2026 1137498147 CMS
Ferring Pharmaceuticals Inc. $7,391.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1137498151 CMS
Ferring Pharmaceuticals Inc. $246.45 03/07/2024 Travel and Lodging Undisputed 01/23/2026 1137498156 CMS
Ferring Pharmaceuticals Inc. $725.10 03/07/2024 Travel and Lodging Undisputed 01/23/2026 1137498160 CMS
Ferring Pharmaceuticals Inc. $325.45 03/07/2024 Travel and Lodging Undisputed 01/23/2026 1137498164 CMS
Ferring Pharmaceuticals Inc. $5,446.00 03/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137498168 CMS
Ferring Pharmaceuticals Inc. $1,556.00 03/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137498172 CMS
Ferring Pharmaceuticals Inc. $38.62 04/02/2024 Food and Beverage Undisputed 01/23/2026 1137498177 CMS
Ferring Pharmaceuticals Inc. $58.35 05/07/2024 Food and Beverage Undisputed 01/23/2026 1137498182 CMS
Ferring Pharmaceuticals Inc. $38.30 05/29/2024 Food and Beverage Undisputed 01/23/2026 1137498187 CMS
Ferring Pharmaceuticals Inc. $137.55 08/22/2024 Food and Beverage Undisputed 01/23/2026 1137498191 CMS
Ferring Pharmaceuticals Inc. $49.01 08/23/2024 Food and Beverage Undisputed 01/23/2026 1137498196 CMS
Ferring Pharmaceuticals Inc. $59.90 08/23/2024 Food and Beverage Undisputed 01/23/2026 1137498200 CMS
Ferring Pharmaceuticals Inc. $32.67 08/23/2024 Food and Beverage Undisputed 01/23/2026 1137498204 CMS
Ferring Pharmaceuticals Inc. $167.49 08/23/2024 Travel and Lodging Undisputed 01/23/2026 1137498208 CMS
Ferring Pharmaceuticals Inc. $717.07 08/23/2024 Travel and Lodging Undisputed 01/23/2026 1137498212 CMS
Ferring Pharmaceuticals Inc. $43.36 08/23/2024 Travel and Lodging Undisputed 01/23/2026 1137498216 CMS
Ferring Pharmaceuticals Inc. $5,446.00 08/23/2024 Consulting Fee Undisputed 01/23/2026 1137498221 CMS
Organon Llc $16.43 02/13/2024 Food and Beverage Undisputed 01/23/2026 1136202431 CMS
Organon Llc $16.96 04/09/2024 Food and Beverage Undisputed 01/23/2026 1136202433 CMS
Organon Llc $13.68 07/09/2024 Food and Beverage Undisputed 01/23/2026 1136202437 CMS
Organon Llc $16.78 10/01/2024 Food and Beverage Undisputed 01/23/2026 1136202435 CMS
Organon Llc $17.04 12/10/2024 Food and Beverage Undisputed 01/23/2026 1136190798 CMS
Sumitomo Pharma America, Inc. $27.93 04/12/2024 Food and Beverage Undisputed 01/23/2026 1148895125 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.